Clinical Trials Browser

INDUSTRY × Colonic Neoplasms × S 1 (combination) × Clear all

NCT00569335 2012-11-02

Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms